|
|
40
|
|
|
B4913
|
|
|
OMALIREL 150MG INJ (RLS/AHI) OMALIZUMAB
|
|
|
OMALIZUMAB
|
|
|
OMALIREL
|
|
|
150MG VIAL
|
|
|
C
|
|
|
844.86
|
|
|
844.86
|
|
|
150MG
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
RLS
|
|
|
RELIANCE LIFE SCIENCES
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No
|
|
|
4810
|
|
|
RESPIRATORY INFLAMMATORY AGENTS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
RESPIRATORY TRACT AGENTS
|
|
|
|